Kirsty Wetherall

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)

Matthew M.Y. Lee, Katriona Brooksbank, Kirsty Wetherall et al. · Circulation · 2020 · 417 citations · Full text

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 344 citations · Full text

Heart Failure, Intravenous Ferric Derisomaltose, Iron Metabolism +3

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

Isla S. Mackenzie, Ian Ford, George Nuki et al. · The Lancet · 2020 · 322 citations · Full text

Cardiovascular Disease, Gouty Arthritis, Pharmacotherapy +5

Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

Isla S. Mackenzie, Christopher J. Hawkey, Ian Ford et al. · The Lancet · 2022 · 143 citations · Full text

Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction

Caroline Haig, David Carrick, Jaclyn Carberry et al. · JACC. Cardiovascular imaging · 2018 · 66 citations · Full text